Interatrial Septum Stenting for Hypoplastic Left Heart Syndrome in Ex Utero Intrapartum Therapy.
Isabel C Sánchez-EscobarManuel Giraldo-PintoAlejandro Quintero-GomezAndrea AriasAncizar de la PeñaRaúl GarcíaJorge GutierrezAndres UribeRafael Lince-VarelaMiguel Ruz MontesJuan Alberto EspinalRafael Correa-VelasquezPublished in: World journal for pediatric & congenital heart surgery (2023)
Patients with hypoplastic left heart syndrome (HLHS) with intact atrial septum have an increased mortality rate. This presentation occurs in 6% to 10% of cases. We present a patient with fetal diagnosis of HLHS with restrictive atrial septum. We performed a cesarean section at 37 weeks of gestation, and under ex utero intrapartum treatment proceeded with a median sternotomy and transatrial stenting for left atrial decompression due to findings of intact atrial septum on the fetal echocardiogram performed during the procedure. Subsequently, the patient underwent hybrid stage I palliation followed by a comprehensive stage II procedure at five months of age, but unfortunately died from postoperative complications.
Keyphrases
- left atrial
- atrial fibrillation
- case report
- catheter ablation
- mitral valve
- left ventricular
- minimally invasive
- heart failure
- antiplatelet therapy
- gestational age
- percutaneous coronary intervention
- cardiovascular events
- preterm infants
- risk factors
- coronary artery disease
- cardiovascular disease
- stem cells
- combination therapy